Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mural Oncology plc - Ordinary Shares
(NQ:
MURA
)
3.130
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mural Oncology plc - Ordinary Shares
< Previous
1
2
Next >
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
September 26, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
September 23, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
September 10, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024
May 14, 2024
Mural Oncology just reported results for the first quarter of 2024.
Via
InvestorPlace
Mural Oncology to Present at Two Upcoming Investor Conferences
August 27, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 23, 2024
Via
Benzinga
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
August 13, 2024
MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
August 13, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023
March 26, 2024
Mural Oncology just reported results for the fourth quarter of 2023.
Via
InvestorPlace
MURA Stock Earnings: Mural Oncology Reported Results for Q3 2023
December 18, 2023
Mural Oncology just reported results for the third quarter of 2023.
Via
InvestorPlace
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
July 31, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
June 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 09, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
March 26, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
February 02, 2024
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in January
January 15, 2024
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.
Via
InvestorPlace
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
January 08, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.